ciglitazone has been researched along with Adenocarcinoma in 6 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study was performed to investigate the effects of the PPARgamma ligand, ciglitazone, and the involvement of PPARgamma in modulating the growth of human colorectal cancer cells." | 7.74 | Modulation of cell growth and PPARgamma expression in human colorectal cancer cell lines by ciglitazone. ( Darus, HM; Norazmi, MN; Yaacob, NS, 2008) |
| " To identify protein patterns involved in resistance to apoptosis, we studied two colorectal adenocarcinoma cell lines with different growth responses to low-molar concentrations of the thiazolidinedione Ciglitazone: HT29 cells underwent apoptosis, whereas SW480 cells increased cell number." | 3.80 | Autonomous inhibition of apoptosis correlates with responsiveness of colon carcinoma cell lines to ciglitazone. ( Baron, DM; Bayer, E; Gerner, C; Haudek-Prinz, VJ; Kaindl, U; Marian, B; Röhrl, C, 2014) |
| " The present study was performed to investigate the effects of the PPARgamma ligand, ciglitazone, and the involvement of PPARgamma in modulating the growth of human colorectal cancer cells." | 3.74 | Modulation of cell growth and PPARgamma expression in human colorectal cancer cell lines by ciglitazone. ( Darus, HM; Norazmi, MN; Yaacob, NS, 2008) |
| "Finally, the effect of 15d-PGJ2 on pancreatic cancer cell invasiveness and matrix metalloproteinase expression was determined." | 1.31 | Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. ( Ethridge, RT; Evers, BM; Hashimoto, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, DM | 1 |
| Kaindl, U | 1 |
| Haudek-Prinz, VJ | 1 |
| Bayer, E | 1 |
| Röhrl, C | 1 |
| Gerner, C | 1 |
| Marian, B | 1 |
| Yaacob, NS | 1 |
| Darus, HM | 1 |
| Norazmi, MN | 1 |
| Hashimoto, K | 1 |
| Ethridge, RT | 1 |
| Evers, BM | 1 |
| Burgermeister, E | 1 |
| Tencer, L | 1 |
| Liscovitch, M | 1 |
| Atarod, EB | 1 |
| Kehrer, JP | 1 |
| Chang, TH | 1 |
| Szabo, E | 1 |
6 other studies available for ciglitazone and Adenocarcinoma
| Article | Year |
|---|---|
Autonomous inhibition of apoptosis correlates with responsiveness of colon carcinoma cell lines to ciglitazone.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Color | 2014 |
Modulation of cell growth and PPARgamma expression in human colorectal cancer cell lines by ciglitazone.
Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Down-Regulation; D | 2008 |
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Topics: 3T3 Cells; Adenocarcinoma; alpha Catenin; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; C | 2002 |
Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Topics: Adenocarcinoma; Antigens, Differentiation; Antigens, Neoplasm; Breast Neoplasms; Caveolin 1; Caveoli | 2003 |
Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines.
Topics: Adenocarcinoma; Apoptosis; Cell Death; Cell Line; Cell Line, Tumor; Humans; Hypoglycemic Agents; Jur | 2004 |
Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blotting, Western; Carc | 2002 |